TempraMed Technologies Ltd
Company Profile
Business description
TempraMed Technologies Ltd develops patent-protected solutions for managing and protecting temperature-sensitive medications. Its product range includes VIVI Cap for insulin pens and VIVI Epi for epinephrine injectors, which are distributed through pharmacy and retail networks globally. TempraMed generates the majority of its revenue from the sales of these devices, serving patients, healthcare providers, and pharmacy systems through operations in Southeast Asia, Europe, and Central America. The company enhances its reach by forming partnerships in the healthcare sector to broaden its access and drive usage in various geographic markets.
Contact
2600 - 1066 West Hastings Street
VancouverBCV6E 3X1
CANT: +1 604 833-6820
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
Chart of the Week: Has gold reached bear market territory?
stocks
Fair value upgrade for this ASX income player
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,885.60 | 59.90 | 0.68% |
| CAC 40 | 7,974.82 | 157.88 | 2.02% |
| DAX 40 | 23,287.09 | 607.05 | 2.68% |
| Dow JONES (US) | 46,691.87 | 1,475.73 | 3.26% |
| FTSE 100 | 10,345.53 | 169.08 | 1.66% |
| HKSE | 25,294.03 | 505.89 | 2.04% |
| NASDAQ | 21,847.18 | 1,052.54 | 5.06% |
| Nikkei 225 | 53,739.68 | 2,675.96 | 5.24% |
| NZX 50 Index | 12,825.87 | 86.24 | -0.67% |
| S&P 500 | 6,581.00 | 52.48 | 0.80% |
| S&P/ASX 200 | 8,671.80 | 53.10 | 0.62% |
| SSE Composite Index | 3,948.55 | 56.69 | 1.46% |